June 28, 2022

At a previous Vaccines and Related Biological Products Advisory (VRBPAC) meeting on April 6, 2022, the committee discussed considerations that should inform strain composition decisions to ensure that available COVID-19 vaccines continue to meet public health needs, when and how frequently to consider strain composition changes, and the process that should be used for making a recommendation for updating the vaccine strain composition.

As a follow-up to the April 6th VRBPAC discussion, this June 28th, 2022 VRBPAC meeting is being held to discuss whether and how the SARS-CoV-2 strain composition of COVID-19 vaccines should be modified.